Breast implant‒associated anaplastic large cell lymphoma (BIA-ALCL), first reported in 1997 [1], is a CD30-positive, anaplastic lymphoma kinase (ALK) ‒negative T-cell lymphoma [2,3]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.